Two Sigma Investments
TSBX

Two Sigma Investments’s Turnstone Biologics TSBX Stock Holding History

Two Sigma Investments’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,500
Closed -$171K – 3394
2023
Q3 		$171K Buy
+43,500
New +$388K ﹤0.01% 2668

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Two Sigma Investments's TSBX Position: Q4 2023 in Review

Two Sigma Investments sold out of Turnstone Biologics (TSBX) in Q4 2023, closing a stake of 43,500 shares — an estimated $171K sold.

Two Sigma Investments first reported a position in TSBX in Q3 2023 and held it in 1 quarter. The position peaked at $171K in Q3 2023. 36 funds tracked by Wall St. Rank hold TSBX as of Q4 2023.

  • Two Sigma Investments reported no remaining Turnstone Biologics position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 43,500 Turnstone Biologics shares in Q4 2023, an estimated $171K.
  • Two Sigma Investments first reported a position in Turnstone Biologics in Q3 2023 and held it in 1 quarter.
  • Two Sigma Investments's Turnstone Biologics position peaked at $171K in Q3 2023.
  • 36 funds tracked by Wall St. Rank held Turnstone Biologics as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.